What is normal anyway? What’s normal for the spider is chaos to the fly.
Not only do Fibromyalgia patients experience nerve pain but they also live with chronic muscle pain, tiredness, mental fatigue (known as fibro fog), as well as restlessness, headaches and joint pain.
So, could pain patches be the future of opioid alternatives for Fibromyalgia?
Photo Courtesy: Cannabis.net
A History Lesson
We can thank Cannabis Science, Inc. a pharmaceutical analysis corporation for producing the cannabis patch. The company is also known for founding several other medicinal innovations — all originating from cannabis.
In the early days of 2016, Cannabis Science began recruiting participants for a clinical trial on the influence of inhaled cannabis formulas on people with respiratory illnesses such as asthma and COPD.
Flash forward a few months, the green corporation revealed a project, which is the transdermal patch decked with strong pain-relieving cannabis medication used to treat fibromyalgia as well as diabetic neuropathy. The patch was tested on 16 patients diagnosed with diabetic neuropathy. After months of follow up appointments and screenings, the results were astounding.
The National Pain Foundation reported that the herb worked better at battling pain as opposed to the driving prescriptions for fibromyalgia, including Savella, Cymbalta and Lyrica.
Cannabis Science says that both patches will hold cannabinoids specifically formulated for the specific condition that will deliver pain relief to the entire body. This is just the beginning, guys.
“The development of these two new pharmaceutical medicinal applications are just the tip of the iceberg for what we see as the future for Cannabis Science,” wrote Cannabis Science CEO, Raymond Dabney in a press release.
Peel and Stick
The healing properties of cannabis are delivered through the skin as it enters the bloodstream when the patients apply the patch to a region on the body. Most patches are worn either on the upper arm of preference or the stomach area.
Photo Courtesy: Cannabis.net
The transdermal patch releases cannabis over time to aid patients in combatting their neurological pain with ease. You simply peel the cover off the patch and apply the sticky side to your skin. It’s best for discrete, all-day pain relief without any hassle.
What cannabis products provide that opioid medications can’t are in regards to the negative side effects and withdrawal symptoms. You get the pain relieving properties without worrying about addiction, overdose and dependence.
Based on numerous studies, no unwanted side effects have been reported. In addition, the specific method of administration is said to be the most effective way to obtain full body relief.
These patches contain high strains of cannabinoid (CBD) extract, which is the second major cannabinoid in the marijuana family, following THC (tetrahydrocannabinol).
The product gradually infiltrates the bloodstream leading to penetration of the patient’s central nervous system to serve as a painkiller.
According to Medical Marijuana Inc., “CBD interacts with the body through the endogenous cannabinoid system (ECS) or endocannabinoid system. First discovered in the late 1980s, the endocannabinoid system regulates the body’s homeostasis, or general state of balance, impacting such functions as mood, sleep, appetite, hormone regulation and pain and immune response.”
CBD has pain-relieving as well as anti-inflammatory components without any psychoactive effects because it’s made with high CBD, low-THC hemp. Unlike marijuana products, which are usually made from plants with high concentrations of psychoactive THC, hemp contains only trace amounts of THC.
Research suggests that hemp oil products are an effective treatment for many types of pain, particularly inflammatory pain. Other studies even say that CBD has may outperform more mainstream medications when it comes to treating inflammatory pain.
It’s a safer, less controversial alternative while still offering significant health benefits for your nerve pain relief.
“While we strive to increase our land capacity for growth and facilities to produce our own product to supply our scientists with proprietary materials to make these formulations, we are also busy researching more potential needs for Cannabis related medical applications and developing the methods for delivery of these medications,” Dabney added.
“As more states nationwide [in the U.S.] legislate for the legalization of cannabis and cannabis-derived medications, we here at Cannabis Science are focused on developing pharmaceutical formulations and applications to supply the huge growing demand expected over the coming few years.”